Genetic risk factors for chemotherapy-induced nausea and vomiting in patients with cancer receiving cisplatin-based chemotherapy (Q47572599)

4 February 2018

http://europepmc.org/abstract/MED/29177570

title

Genetic risk factors for chemotherapy-induced nausea and vomiting in patients with cancer receiving cisplatin-based chemotherapy (English)

1 reference

4 February 2018

http://europepmc.org/abstract/MED/29177570

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29177570%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29177570%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29177570%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Mari Yokoi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29177570%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Daiki Tsuji

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29177570%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Kenichi Suzuki

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29177570%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Masahiko Nakao

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29177570%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Hideaki Ayuhara

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29177570%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Yuuki Kogure

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29177570%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Kazuhiko Shibata

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29177570%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Toshinobu Hayashi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29177570%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Kazuyuki Inoue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29177570%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Toshihiro Hama

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29177570%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Koji Takeda

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29177570%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Makoto Nishio

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29177570%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

publication date

24 November 2017

1 reference

4 February 2018

http://europepmc.org/abstract/MED/29177570

published in

Supportive Care in Cancer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29177570%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29177570%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29177570%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

page(s)

1505-1513

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29177570%20AND%20SRC:MED&resulttype=core&format=json

Nausea and emesis remain significant problems of chemotherapy despite prophylaxis with 5-hydroxytryptamine-3 antiemetics: a University of Rochester James P. Wilmot Cancer Center Community Clinical Oncology Program Study of 360 cancer patients treate

10 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00520-017-3974-3

Chemotherapy-induced nausea and vomiting in routine practice: a European perspective.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-017-3974-3

A prospective observational study of chemotherapy-related nausea and vomiting in routine practice in a UK cancer centre

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-017-3974-3

Comparison of an aprepitant regimen with a multiple-day ondansetron regimen, both with dexamethasone, for antiemetic efficacy in high-dose cisplatin treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-017-3974-3

Establishing the dose of the oral NK1 antagonist aprepitant for the prevention of chemotherapy-induced nausea and vomiting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-017-3974-3

Efficacy and tolerability of aprepitant for the prevention of chemotherapy-induced nausea and vomiting in patients with breast cancer after moderately emetogenic chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-017-3974-3

Usefulness of antiemetic therapy with aprepitant, palonosetron, and dexamethasone for lung cancer patients on cisplatin-based or carboplatin-based chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-017-3974-3

Randomized, double-blind, phase III trial of palonosetron versus granisetron in the triplet regimen for preventing chemotherapy-induced nausea and vomiting after highly emetogenic chemotherapy: TRIPLE study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-017-3974-3

Methodology of antiemetic trials: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-017-3974-3

Risk factors of chemotherapy-induced nausea and vomiting: index for personalized antiemetic prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-017-3974-3

Evaluation of risk factors predicting chemotherapy-related nausea and vomiting: results from a European prospective observational study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-017-3974-3

Testing the effectiveness of antiemetic guidelines: results of a prospective registry by the CINV Study Group of Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-017-3974-3

Patient-tailored antiemetic treatment with 5-hydroxytryptamine type 3 receptor antagonists according to cytochrome P-450 2D6 genotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-017-3974-3

Variations in the 5-hydroxytryptamine type 3B receptor gene as predictors of the efficacy of antiemetic treatment in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-017-3974-3

Polymorphisms in the novel serotonin receptor subunit gene HTR3C show different risks for acute chemotherapy-induced vomiting after anthracycline chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-017-3974-3

Association of the ABCB1 3435C>T polymorphism with antiemetic efficacy of 5-hydroxytryptamine type 3 antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-017-3974-3

Dexamethasone alone or in combination with ondansetron for the prevention of delayed nausea and vomiting induced by chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-017-3974-3

Polymorphism in HTR3D shows different risks for acute chemotherapy-induced vomiting after anthracycline chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-017-3974-3

Association of ABCB1, 5-HT3B receptor and CYP2D6 genetic polymorphisms with ondansetron and metoclopramide antiemetic response in Indonesian cancer patients treated with highly emetogenic chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-017-3974-3

Association of ABCB1 polymorphisms with the antiemetic efficacy of granisetron plus dexamethasone in breast cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-017-3974-3

A review of excision repair cross-complementation group 1 in colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-017-3974-3

Excision repair cross-complementation group 1 polymorphism predicts overall survival in advanced non-small cell lung cancer patients treated with platinum-based chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-017-3974-3

Polymorphisms in ERCC1 and grade 3 or 4 toxicity in non-small cell lung cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-017-3974-3

Investigation of HTR3C mutations for association with 5HT(3) receptor antagonist anti-emetic efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-017-3974-3

Influence of ABCB1 and ABCG2 polymorphisms on the antiemetic efficacy in patients with cancer receiving cisplatin-based chemotherapy: a TRIPLE pharmacogenomics study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-017-3974-3

Genetic polymorphisms of the human MDR1 drug transporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-017-3974-3

A new look at the statistical model identification

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-017-3974-3

Comparison of ERCC1/XPF genetic variation, mRNA and protein levels in women with advanced stage ovarian cancer treated with intraperitoneal platinum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-017-3974-3

Course, patterns, and risk-factors for chemotherapy-induced emesis in cisplatin-pretreated patients: a study with ondansetron

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-017-3974-3

Prognostic factors influencing cisplatin-induced emesis. Definition and validation of a predictive logistic model

21 January 2018

1 reference

12 December 2020

Decreased cisplatin-induced nausea and vomiting with chronic alcohol ingestion

1 reference

12 December 2020

Association of an ERCC1 polymorphism with adult-onset glioma.

1 reference

12 December 2020

MDR1 genotype-related pharmacokinetics of digoxin after single oral administration in healthy Japanese subjects

1 reference

12 December 2020

Significant genetic linkage of MDR1 polymorphisms at positions 3435 and 2677: functional relevance to pharmacokinetics of digoxin

1 reference

12 December 2020

Chemotherapy-induced nausea and vomiting in breast cancer patients: a prospective observational study

1 reference

12 December 2020

10.1007/S00520-017-3974-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29177570%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29177570%20AND%20SRC:MED&resulttype=core&format=json